{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:42:55Z","timestamp":1780440175419,"version":"3.54.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"public, commercial or not-for-profit"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To investigate whether the auto-inflammatory nature and the pathergic reaction in Beh\u00e7et\u2019s disease (BD) are driven by a disturbed toll-like receptor (TLR) response.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We compared both TLR expression by flow-cytometry and TLR response by stimulation assay in 18 BD patients (both pathergy positive and pathergy negative) with 15 healthy controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Expression of TLR1 and 2 was significantly elevated in B-lymphocytes of BD patients compared with healthy controls. TLR1, 2 and 4 were significantly more highly expressed in both CD4+ and CD8+ T-lymphocytes of BD patients. Granulocytes of BD patients displayed significantly higher expression of TLR1, 2, 4 and 6. TLR2, 4 and 5 expression was significantly increased on classical monocytes of BD patients. Intermediate monocytes of BD patients showed an increase in expression of TLR2. Furthermore, TLR2 and 5 were significantly more highly expressed in non-classical monocytes of BD patients. In pathergy positive patients, TLR5 was even more highly expressed compared with pathergy negative patients on B- and T-lymphocytes and granulocytes. Furthermore, TLR2 and 5 showed an elevated TNF-\u03b1 response to stimulation with their cognate ligands.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Immune cells of BD patients overexpress TLR1, 2, 4, 5 and 6. Furthermore, after stimulation of TLR2 and 5, BD patients demonstrate a more potent TNF-\u03b1 response. Although this is a small cohort, in the pathergy positive patients, TLR5 expression is even further augmented, suggesting that a microbial (flagellin) or damage (HMGB1) associated signal may trigger the exaggerated immune response that is characteristic for the pathergy phenomenon in BD. In conclusion, these results point to an exaggerated TLR response in the auto-inflammatory nature of BD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa251","type":"journal-article","created":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T19:06:47Z","timestamp":1587236807000},"page":"3971-3979","source":"Crossref","is-referenced-by-count":22,"title":["Leukocyte toll-like receptor\u2002expression in pathergy positive and negative Beh\u00e7et\u2019s disease patients"],"prefix":"10.1093","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5896-7033","authenticated-orcid":false,"given":"Tim B","family":"van der Houwen","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Section Clinical Immunology"},{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A","family":"Dik","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Goeijenbier","sequence":"additional","affiliation":[{"name":"Department of Viroscience, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manizhah","family":"Hayat","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section Clinical Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M A","family":"Nagtzaam","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"van Hagen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section Clinical Immunology"},{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A M","family":"van Laar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section Clinical Immunology"},{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"key":"2020121319241751900_keaa251-B1","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u00e7et\u2019s disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"2020121319241751900_keaa251-B2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00281-015-0502-8","article-title":"Pathogenesis of Beh\u00e7et\u2019s disease: autoinflammatory features and beyond","volume":"37","author":"G\u00fcl","year":"2015","journal-title":"Semin Immunopathol"},{"key":"2020121319241751900_keaa251-B3","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"2020121319241751900_keaa251-B4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.survophthal.2005.04.009","article-title":"Current concepts in the etiology and treatment of Beh\u00e7et disease","volume":"50","author":"Evereklioglu","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"2020121319241751900_keaa251-B5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00296-005-0029-8","article-title":"Serum interleukin-18 levels in patients with Beh\u00e7et\u2019s disease. Is its expression associated with disease activity or clinical presentations?","volume":"26","author":"Musabak","year":"2006","journal-title":"Rheumatol Int"},{"key":"2020121319241751900_keaa251-B6","first-page":"849","article-title":"Neutrophil CD64 expression in Beh\u00e7et's disease","volume":"32","author":"Ureten","year":"2005","journal-title":"J Rheumatol"},{"key":"2020121319241751900_keaa251-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/705831","article-title":"Gamma delta (\u03b3\u03b4) T cells and their involvement in Beh\u00e7et\u2019s disease","volume":"2015","author":"Hasan","year":"2015","journal-title":"J Immunol Res"},{"key":"2020121319241751900_keaa251-B8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/BOR.0b013e3283534df4","article-title":"Pathogenesis of spondyloarthritis: autoimmune or autoinflammatory?","volume":"24","author":"Ambarus","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"2020121319241751900_keaa251-B9","first-page":"471","article-title":"Beh\u00e7et\u2019s disease, hospital-based prevalence and manifestations in the Rotterdam area","volume":"73","author":"Kappen","year":"2015","journal-title":"Neth J Med"},{"key":"2020121319241751900_keaa251-B10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00403-009-1008-9","article-title":"The skin pathergy test: innately useful?","volume":"302","author":"Varol","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"2020121319241751900_keaa251-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8473-z","article-title":"Toll-like receptor pathways in autoimmune diseases","volume":"50","author":"Chen","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"2020121319241751900_keaa251-B12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fphar.2017.00304","article-title":"Anti-tumor activity of toll-like receptor 7 agonists","volume":"8","author":"Chi","year":"2017","journal-title":"Front Pharmacol"},{"key":"2020121319241751900_keaa251-B13","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/35021228","article-title":"Toll-like receptors in the induction of the innate immune response","volume":"406","author":"Aderem","year":"2000","journal-title":"Nature"},{"key":"2020121319241751900_keaa251-B14","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1167\/iovs.13-12159","article-title":"Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet\u2019s disease","volume":"54","author":"Liu","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020121319241751900_keaa251-B15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/1753425913498042","article-title":"The role of TLR2 and 4 in Beh\u00e7et\u2019s disease pathogenesis","volume":"20","author":"Seoudi","year":"2014","journal-title":"Innate Immun"},{"key":"2020121319241751900_keaa251-B16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00296-007-0470-y","article-title":"Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behcet\u2019s disease etiopathogenesis","volume":"28","author":"Yavuz","year":"2008","journal-title":"Rheumatol Int"},{"key":"2020121319241751900_keaa251-B17","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et\u2019s disease","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"2020121319241751900_keaa251-B18","volume-title":"Beh\u00e7et\u2019s disease current activity form","year":"2006"},{"key":"2020121319241751900_keaa251-B19","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/leu.2012.122","article-title":"EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols","volume":"26","author":"Kalina","year":"2012","journal-title":"Leukemia"},{"key":"2020121319241751900_keaa251-B20","doi-asserted-by":"crossref","first-page":"e18279","DOI":"10.1371\/journal.pone.0018279","article-title":"Potent innate immune response to pathogenic leptospira in human whole blood","volume":"6","author":"Goris","year":"2011","journal-title":"PLoS One"},{"key":"2020121319241751900_keaa251-B21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1474-9726.2011.00759.x","article-title":"Age-associated elevation in TLR5 leads to increased inflammatory responses in the elderly","volume":"11","author":"Qian","year":"2012","journal-title":"Aging Cell"},{"key":"2020121319241751900_keaa251-B22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2249.2009.04036.x","article-title":"Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus","volume":"159","author":"Wong","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"2020121319241751900_keaa251-B23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bbmt.2012.09.013","article-title":"Profile of toll-like receptors on peripheral blood cells in relation to acute graft-versus-host disease after allogeneic stem cell transplantation","volume":"19","author":"Skert","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020121319241751900_keaa251-B24","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1053\/j.gastro.2005.03.046","article-title":"Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn\u2019s disease","volume":"128","author":"Targan","year":"2005","journal-title":"Gastroenterology"},{"key":"2020121319241751900_keaa251-B25","doi-asserted-by":"crossref","first-page":"13610","DOI":"10.1073\/pnas.0502174102","article-title":"Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation","volume":"102","author":"Rhee","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020121319241751900_keaa251-B26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2133.1995.tb16946.x","article-title":"Immunohistology of skin pathergy reaction in Beh\u00e7et\u2019s disease","volume":"132","author":"G\u00fcl","year":"2010","journal-title":"Br J Dermatol"},{"key":"2020121319241751900_keaa251-B27","first-page":"747","article-title":"Beh\u00e7et\u2019s syndrome. Immunopathologic and histopathologic assessment of pathergy lesions is useful in diagnosis and follow-up","volume":"109","author":"Jorizzo","year":"1985","journal-title":"Arch Pathol Lab Med"},{"key":"2020121319241751900_keaa251-B28","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1046\/j.1365-4362.1998.00474.x","article-title":"The histopathology of pathergy: a chronologic study of skin hyperreactivity in Beh\u00e7et\u2019s disease","volume":"37","author":"Ergun","year":"1998","journal-title":"Int J Dermatol"},{"key":"2020121319241751900_keaa251-B29","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.celrep.2016.09.076","article-title":"HMGB1 activates proinflammatory signaling via TLR5 leading to allodynia","volume":"17","author":"Das","year":"2016","journal-title":"Cell Rep"},{"key":"2020121319241751900_keaa251-B30","first-page":"2151","article-title":"High mobility group box 1 serum levels are increased in Beh\u00e7et\u2019s disease, but not associated with disease activity or disease manifestations","volume":"54","author":"de Souza","year":"2015","journal-title":"Rheumatology"},{"key":"2020121319241751900_keaa251-B31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/ard.52.8.619","article-title":"Effect of surgical cleaning of the skin on the pathergy phenomenon in Beh\u00e7et\u2019s syndrome","volume":"52","author":"Fresko","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"2020121319241751900_keaa251-B32","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/rheumatology\/ken109","article-title":"Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet\u2019s disease","volume":"47","author":"Do","year":"2008","journal-title":"Rheumatology"},{"key":"2020121319241751900_keaa251-B33","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/ibd.21282","article-title":"Toll-like receptors in inflammatory bowel diseases: a decade later","volume":"16","author":"Cario","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"2020121319241751900_keaa251-B34","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/978-1-4419-0298-6_23","article-title":"Innate immunity of spondyloarthritis: the role of toll-like receptors","volume":"649","author":"Inman","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"2020121319241751900_keaa251-B35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.clim.2005.12.005","article-title":"TNF alpha production to TLR2 ligands in active IBD patients","volume":"119","author":"Cant\u00f3","year":"2006","journal-title":"Clin Immunol"},{"key":"2020121319241751900_keaa251-B36","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/art.21155","article-title":"Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy","volume":"52","author":"De Rycke","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2020121319241751900_keaa251-B37","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1053\/gast.2002.33662","article-title":"Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation","volume":"122","author":"Hausmann","year":"2002","journal-title":"Gastroenterology"},{"key":"2020121319241751900_keaa251-B38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/jir.2010.0095","article-title":"Toll-like receptors as interferon-regulated genes and their role in disease","volume":"31","author":"Khoo","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"2020121319241751900_keaa251-B39","doi-asserted-by":"crossref","first-page":"4246965","DOI":"10.1155\/2018\/4246965","article-title":"Gene expression profiling in Behcet\u2019s disease indicates an autoimmune component in the pathogenesis of the disease and opens new avenues for targeted therapy","volume":"2018","author":"Puccetti","year":"2018","journal-title":"J Immunol Res"},{"key":"2020121319241751900_keaa251-B40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.gene.6363791","article-title":"IFNs activate toll-like receptor gene expression in viral infections","volume":"2","author":"Miettinen","year":"2001","journal-title":"Genes Immun"},{"key":"2020121319241751900_keaa251-B41","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.semarthrit.2003.09.010","article-title":"The use of interferon alpha in Beh\u00e7et disease: review of the literature","volume":"33","author":"K\u00f6tter","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"2020121319241751900_keaa251-B42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/039463201102400121","article-title":"Modulation of toll-like receptors in psoriatic patients during therapy with adalimumab","volume":"24","author":"De Pit\u00e0","year":"2011","journal-title":"Int J Immunopathol Pharmacol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/12\/3971\/34890332\/keaa251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/12\/3971\/34890332\/keaa251.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:24:59Z","timestamp":1607905499000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/12\/3971\/5881460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,8,5]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa251","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,8,5]]}}}